Clinical trial
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation…
NCT00089596 · ViaCell, Industry · Completed
Key facts
| NCT number | NCT00089596 |
|---|---|
| Title | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers |
| Official title | A Safety Study of Infusion of Ex Vivo Selectively Amplified Unrelated Cord Blood Stem Cells in Subjects With Hematological Malignancies Receiving Unrelated Cord Blood Transplantation |
| Lead sponsor | ViaCell, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin Lymphoma, Chronic Myelogenous Leukemia |
| Intervention type | Procedure |
| Interventions | Expansion of umbilical cord stem cells |
| Enrollment | 10 |
| Start date | Mar 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Aug 10, 2004 |
| Last update posted | Apr 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: